Skip to main content
Top
Published in: Clinical & Experimental Metastasis 2/2000

01-03-2000

Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro

Authors: Malika Balduyck, Farid Zerimech, Valérie Gouyer, Raphael Lemaire, Brigitte Hemon, Georges Grard, Carole Thiebaut, Véronique Lemaire, Evelyne Dacquembronne, Thérèse Duhem, Anne Lebrun, Marie-José Dejonghe, Guillemette Huet

Published in: Clinical & Experimental Metastasis | Issue 2/2000

Login to get access
Metadata
Title
Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro
Authors
Malika Balduyck
Farid Zerimech
Valérie Gouyer
Raphael Lemaire
Brigitte Hemon
Georges Grard
Carole Thiebaut
Véronique Lemaire
Evelyne Dacquembronne
Thérèse Duhem
Anne Lebrun
Marie-José Dejonghe
Guillemette Huet
Publication date
01-03-2000
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 2/2000
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006762425323

Other articles of this Issue 2/2000

Clinical & Experimental Metastasis 2/2000 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine